Quantcast
Channel: MassDevice
Browsing all 11157 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Medtronic joins Masimo CEO Kiani’s Patient Safety Foundation, pledges $5m

Despite being rivals in the blood oxygen diagnostic fields, Medtronic (NYSE:MDT) said it is joining Masimo (NSDQ:MASI) CEO Joe Kiani’s Patient Safety Movement Foundation with a $5 million, 5-year...

View Article


Image may be NSFW.
Clik here to view.

Boston Scientific, University of Alabama settle CRM patent spat

Boston Scientific (NYSE:BSX) and the University of Alabama settled a patent dispute over cardiac rhythm management technology. The spat spans back to 2014, when the University of Alabama at Birmingham...

View Article


Image may be NSFW.
Clik here to view.

CMS acting chief Slavitt slams drug pricing

Centers for Medicare & Medicaid Services acting chief Andy Slavitt admonished pharma companies like Mylan (NSDQ:MYL) over unsustainable price increases before the Biopharma Congress in Washington...

View Article

Image may be NSFW.
Clik here to view.

Abbott wins Japanese approval for Absorb

Abbott (NYSE:ABT) said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its Absorb bioresorbable heart stent, touting it as the 1st fully dissolving heart stent...

View Article

Image may be NSFW.
Clik here to view.

Propeller wins FDA nod for connected GSK Ellipta inhaler

Propeller Health said today that it won 510(k) clearance from the FDA to market its Propeller platform with GlaxoSmithKline‘s (NYSE:GSK) Ellipta inhaler. A sensor for the dry powder inhaler was built...

View Article


Image may be NSFW.
Clik here to view.

St. Jude wins CE Mark for MRI safe labeling for Quadra CRT-P

St. Jude Medical (NYSE:STJ) said today it won CE Mark approval in the European Union to add magnetic resonance imaging conditional labeling to its Quadra Allure MP cardiac resynchonization therapy...

View Article

Image may be NSFW.
Clik here to view.

PAVmed partners with Boston institutions for antibiotic-eluting ear device

PAVmed Inc. (NSDQ:PAVMU) said today that it inked an exclusive licensing agreement with academic institutions to develop and commercialize antibiotic-eluting resorbable ear tubes based on an aqueous...

View Article

Image may be NSFW.
Clik here to view.

Medical device tax rears its head in more Congressional races

Despite not getting much coverage during the U.S. presidential race, the Medical Device tax has become a hot topic for a handful of Congressional races across the country. The 2.3% medical device tax,...

View Article


Image may be NSFW.
Clik here to view.

Clinton Foundation emails link BD with Russian program

A recently uncovered batch of emails related to the Clinton Foundation indicate that the group sought aid from medtech firm Becton Dickinson & Co. (NYSE:BDX) in helping the Russian Ministry of...

View Article


Image may be NSFW.
Clik here to view.

First patient receives Pixium bionic vision implant

Pixium Vision (EPA:PIX) said today that the 1st patient in the UK was implanted with its IRIS II bionic vision system. The epi-retinal implant has 150 electrodes and a bio-inspired camera intended for...

View Article

Image may be NSFW.
Clik here to view.

Flamel Technologies tops Q3 revenue, EPS estimate

Shares in Flamel Technologies (NSDQ:FLML) rose today after the pharmaceutical company met expectations on Wall Street with its 3rd quarter results. The Venissieux, France-based company posted a loss of...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for November 7, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Philips settles with Masimo for $300m, inks patient monitoring partnership

Masimo (NSDQ:MASI) said today that Royal Philips (NYSE:PHG) agreed to pay $300 million to resolve all outstanding legal disputes between the companies, with both inking a multi-year patient monitoring...

View Article


Image may be NSFW.
Clik here to view.

Siemens picks up point-of-care interface dev Conworx Tech

Siemens Healthineers (NYSE:SI) said today it acquired Berlin-based point-of-care device interface and data management developer Conworx Technology for an undisclosed amount. Siemens will pick up...

View Article

Image may be NSFW.
Clik here to view.

Researchers stunt growth of ovarian cancer with nanohydrogels

Researchers at the Georgia Institute of Technology have developed a targeted therapy using nanohydrogels to stunt the growth of ovarian tumors in in vivo tests in mice, according to a new study. The...

View Article


Image may be NSFW.
Clik here to view.

Biotronik launches high energy Inventra HF-T ICD

Biotronik said today it launched the “ultra-high” energy Inventra HF-T, touting it as the 1st and only implantable cardioverter defibrillator available to deliver 42 joules in the 1st shock. The new...

View Article

Image may be NSFW.
Clik here to view.

Introducing FDA’s emerging sciences idea portal: Please help us predict the...

By: Donna L. Mendrick, Ph.D. Gazing into the future to predict the next new things in science and technology is not just the work of a science fiction writer. Government and business engage in this...

View Article


Image may be NSFW.
Clik here to view.

Third-quarter sales surge more than 50% for Mazor Robotics

Third-quarter sales for Mazor Robotics (NSDQ:MZOR) rose nearly 54% as the robot-assisted surgery company sold more guidance systems than during all of last year. Caesarea, Israel-based Mazor posted...

View Article

Image may be NSFW.
Clik here to view.

Japan OKs Medinol stent trial

Medinol said yesterday that Japanese regulators approved a clinical trial of its Elunir drug-eluting stent that it plans to add to an ongoing U.S. trial of the device. The thin-strut,...

View Article

Image may be NSFW.
Clik here to view.

Catalent tops Q1 estimates, profits fall 61%

Shares in Catalent (NYSE:CTLT) rose yesterday after the drug-delivery company met expectations on Wall Street with its fiscal 1st-quarter results. The Somerset, N.J.-based company posted profits of...

View Article
Browsing all 11157 articles
Browse latest View live